Inventor · disambiguated record
Clarke B. Taylor
Also filed as: TAYLOR CLARKE · TAYLOR CLARKE B · TAYLOR CLARKE BENTLEY
31 granted patents·7 pending applications·465 citations·filing 2001–2020
97Inventor score
Top patents by PatentIndex Score
38 records- 0197US6605617B2Quinolinone derivativesCHIRON CORP·Filed 2001·Granted Aug 12, 2003·174 cites·30 claims
- 0295US6774237B2Quinolinone derivativesCHIRON CORP·Filed 2002·Granted Aug 10, 2004·66 cites·23 claims
- 0392US6800760B2Quinolinone derivativesCHIRON CORP·Filed 2003·Granted Oct 5, 2004·43 cites·20 claims
- 0492US6762194B2Quinolinone derivativesCHIRON CORP·Filed 2003·Granted Jul 13, 2004·46 cites·42 claims
- 0589US9340493B2Hydroxamic acid derivatives useful as antibacterial agentsPFIZER·Filed 2014·Granted May 17, 2016·7 cites·16 claims
- 0689US9266839B2Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2014·Granted Feb 23, 2016·8 cites·53 claims
- 0788US9370507B2Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2015·Granted Jun 21, 2016·8 cites·27 claims
- 0888US9000014B2Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofGLICK GARY D·Filed 2011·Granted Apr 7, 2015·12 cites·26 claims
- 0987US9896441B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2015·Granted Feb 20, 2018·6 cites·58 claims
- 1087US9139532B2Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereofGLICK GARY D·Filed 2011·Granted Sep 22, 2015·8 cites·32 claims
- 1186US9707211B2Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2016·Granted Jul 18, 2017·4 cites·30 claims
- 1285US9580388B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2015·Granted Feb 28, 2017·4 cites·27 claims
- 1385US9169199B2Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofHURD ALEXANDER R·Filed 2011·Granted Oct 27, 2015·8 cites·25 claims
- 1484US9580391B2Saturated acyl guanidine for inhibition of F1F0-ATPaseLYCERA CORP·Filed 2013·Granted Feb 28, 2017·4 cites·30 claims
- 1584US9221814B2Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2013·Granted Dec 29, 2015·8 cites·28 claims
- 1684US7598268B2Quinolinone derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Oct 6, 2009·14 cites·5 claims
- 1781US7196090B2Kinase inhibitorsWARNER LAMBERT CO·Filed 2003·Granted Mar 27, 2007·23 cites·10 claims
- 1880US10442798B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2018·Granted Oct 15, 2019·2 cites·30 claims
- 1980US10364237B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2017·Granted Jul 30, 2019·2 cites·20 claims
- 2079US10421751B2Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Sep 24, 2019·2 cites·26 claims
- 2178US8722686B2Hydroxamic acid derivatives useful as antibacterial agentsBROWN MATTHEW F·Filed 2009·Granted May 13, 2014·5 cites·14 claims
- 2277US10085972B2Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2017·Granted Oct 2, 2018·1 cites·31 claims
- 2376US8604023B21,4-benzodiazepinone compounds and their use in treating cancerGLICK GARY D·Filed 2010·Granted Dec 10, 2013·2 cites·24 claims
- 2475US10189777B2Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2015·Granted Jan 29, 2019·2 cites·24 claims
- 2575US9932313B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2017·Granted Apr 3, 2018·1 cites·25 claims
- 2673US10611740B2Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Apr 7, 2020·1 cites·44 claims
- 2773US10532088B2Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methodsLYCERA CORP·Filed 2015·Granted Jan 14, 2020·2 cites·37 claims
- 2871US9920012B2Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2013·Granted Mar 20, 2018·1 cites·27 claims
- 2971US9914706B2N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2014·Granted Mar 13, 2018·1 cites·26 claims
- 3065US11059796B2Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseUNIV MICHIGAN REGENTS·Filed 2020·Granted Jul 13, 2021·0 cites·20 claims
- 3163US2008070906A1Quinolinone derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 3261US2019175556A1Trifluoromethyl pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2018·Application pending·0 cites
- 3359US2018334438A1Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2018·Application pending·0 cites
- 3457US2003028018A1Quinolinone derivativesCHIRON COPORATION·Filed 2002·Application pending·0 cites
- 3556US2010184754A1Quinolinone derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 3652US10392350B2N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2018·Granted Aug 27, 2019·0 cites·21 claims
- 3747US2022388964A1(aza)indazolyl-aryl sulfonamide and related compounds and their use in treating medical conditionsHIBERCELL INC·Filed 2020·Application pending·0 cites
- 3844US2005096278A1Antibacterial agentsFiled 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →